Pharmaceutical Printed Literature Association

Trade Association

Based in IL

🤖

AI Overview

With $1.4M in lobbying spend across 27 quarterly filings, Pharmaceutical Printed Literature Association is a significant lobbying presence. They deploy 11 individual lobbyists Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$1.4M
Total Spend
8
Years Active
1
Firms Hired
11
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$60K
2019$100K
2020$180K
2021$200K
2022$150K
2023$220K
2024$190K
2025$300K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Defense

Promoting continued access to pharmaceutical printed packaging information.

Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.

Promotion of legislative language within H.R. 2500, the National Defense Authorization Act of 2020, to ensure that prescription drugs made available to Department of Defense military treatment facilities include labels that are printed and physically accompany the package from which the drug is to be dispensed and such label provides adequate directions for use of such drug.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.

Educating offices about paper labeling in FDA appropriations.

Showing 8 of 11 unique descriptions from filings.

Related Analysis

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.